Company Monitoring Page for Bayer

latest headlines for company on cafepharma

Novartis says trials back Beovu safety in diabetic eye disease
Pharmaforum
Tue, 08/17/21 - 10:08 am
Tags:
Novartis, Beovu, diabetic macular edema, Bayer, Regeneron, Eylea
Biotech M&A tracker: After hitting new heights, deals have slowed down. Here are the latest.
BioPharma Dive
Tue, 08/10/21 - 11:12 pm
Tags:
M&A, Bayer, Sanofi, Amgen, uniQure, MorphoSys, Xeris Pharmaceuticals, Relay Therapeutics, Merck, Beam Therapeutics, Jazz Pharmaceuticals
Bayer bets $1.5B that Vividion will help it target the 'undruggable' and make 1+1=3
Fierce Biotech
Thu, 08/5/21 - 11:11 am
Tags:
Bayer, Vividion, M&A, IPOs, R&D
Chasing Merck & Co, Bayer builds case for cough drug eliapixant
Pharmaforum
Wed, 08/4/21 - 10:49 am
Tags:
Bayer, Merck, chronic cough, eliapixant, gefapixant, clinical trials
Drugs facing the most patent expirations this year
Drug Patent Watch
Sun, 08/1/21 - 11:46 pm
Tags:
patents, Novartis, Sunovion, Allergan, Bayer, Gilead Sciences
Bayer's drug that turns a cancer-protective pathway toxic eradicates breast tumors in mice
Fierce Biotech
Wed, 07/21/21 - 08:44 pm
Tags:
Bayer, breast cancer, Systems Oncology, ErSO
FDA gives speedy review to Bayer’s Parkinson’s stem cell therapy
Pharmaforum
Tue, 07/20/21 - 11:14 am
Tags:
Bayer, BlueRock Therapeutics, FDA, DA01, stem cells, Parkinson's Disease
FDA Approvals Roundup: Kerendia, Padcev, Darzalex Faspro
RAPS.org
Thu, 07/15/21 - 12:34 pm
Tags:
FDA, drug approvals, Bayer, Kerendia, Astellas, Padcev, Teva Pharmaceutical, ArmonAir RespiClick, Janssen, Darzalex Faspro
Bayer's Farxiga rival Kerendia scores long-awaited kidney and heart disease nod for Type 2 diabetes patients
Fierce Pharma
Fri, 07/9/21 - 11:58 pm
Tags:
Bayer, finerenone, Kerendia, kidney disease, heart disease, diabetes, type 2 diabetes, Farxiga
After selling its spinout to Bayer in a $875M-plus deal, NeRRe Therapeutics grabs $28M for some 'unfinished business'
Endpoints
Wed, 07/7/21 - 10:58 am
Tags:
NeRRe, Bayer, M&A, Mary Kerr, KaNDy Therapeutics
AskBio, Syndax and Catalyst All on the Fast Track
BioSpace
Mon, 06/28/21 - 06:56 pm
Tags:
FDA, fast track status, AskBio, Bayer, gene therapy, LGMD, Syndax Pharma, leukemia, Catalyst Biosciences, episodic bleeding
In surprising flop, Exelixis' Cabometyx combo with Roche's Tecentriq fails to extend life in liver cancer
Fierce Pharma
Mon, 06/28/21 - 10:50 am
Tags:
Exelixis, Cabometyx, liver cancer, Bayer, Nexavar
'We're Not Gonna Take It'—Bayer and Twisted Sister rocker join nonprofit to push back on prostate cancer
Fierce Pharma
Fri, 06/18/21 - 10:10 am
Tags:
Bayer, pharma marketing, prostate cancer
GSK, Bayer stand by CureVac following 'disappointing' COVID-19 vaccine trial flop
Fierce Pharma
Thu, 06/17/21 - 10:44 pm
Tags:
CureVac, Bayer, GSK, vaccines, COVID19
Bayer pledges $300M to boost production in world's 'contraceptive capital’
Fierce Pharma
Sat, 06/12/21 - 10:25 pm
Tags:
Bayer, Europe, drug manufacturing, contraceptives
Bayer's billon-dollar Parkinson's disease bets land in the clinic
Fierce Biotech
Tue, 06/8/21 - 11:15 am
Tags:
Bayer, Parkinson's Disease, DA01, BlueRock Therapeutics
Bayer at ASCO: Vitrakvi Effective in TRK Fusion Cancers Regardless of Tumor Type
BioSpace
Sun, 06/6/21 - 10:31 pm
Tags:
Bayer, ASCO 2021, Vitrakvi, cancer
Bayer picks up radiotherapeutics biotech to prop up dwindling sales in prostate cancer program
Fierce Biotech
Thu, 06/3/21 - 10:50 am
Tags:
Bayer, radiotherapeutics, Noria Therapeutics, M&A, PSMA Therapeutics
Bayer’s investment arm leads digital health startup’s $90M round
MedCity News
Tue, 06/1/21 - 10:42 pm
Tags:
Bayer, digital health, artificial intelligence, Ada Health
Bayer backs Ada Health’s symptom checker app in $90m financing
Pharmaforum
Thu, 05/27/21 - 11:02 am
Tags:
Bayer, Ada Health, patients, venture capital, mobile apps

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.